The Arkansas Supreme Court ruled in favor of drug maker Johnson & Johnson (J&J) regarding a $1.2 billion dollar Risperdal verdict stemming from lawsuits over the company's marketing of the antipsychotic medication. Arkansas's attorney general alleged J&J used deceptive marketing that made inflated claims of the... Read More

In January 2014, a divided Louisiana Supreme Court reversed a decision awarding the state Attorney General $257 million in a Risperdal lawsuit against Janssen Pharmaceuticals and its parent corporation Johnson & Johnson, Inc. In a 4-3 decision, the Court ruled that the drug manufacturers had... Read More

Federal agents placed a hidden recording device on Johnson & Johnson (J&J) sales representative Judy Doetterl in 2004, and directed her to tape marketing presentations at a national company sales meeting. U.S. prosecutors were trying to prove claims that J&J increased sales by encouraging physicians... Read More

Recently, internal documents were released that strongly suggested Johnson & Johnson, the manufacturer of Risperdal, concealed evidence that linked the drug to serious side effects. These Risperdal side effects became evident in a clinical trial dubbed RIS 232. The internal documents, which were released by... Read More

Dozens of plaintiffs who had filed a Risperdal gynecomastia lawsuit against Johnson & Johnson had reached settlement agreements on January 28, 2013. However, it recently came to light that the drug maker is allegedly trying to back out of the already agreed-upon settlement deal. Attorneys... Read More

As reported by Bloomberg News and the U.S. Department of Justice, Johnson & Johnson and its subsidiaries will pay $2 billion to resolve both civil and criminal charges over misbranding of its drugs Risperdal, Invega and Natrecor for uses that were not FDA approved. The... Read More

Risperdal received FDA approval in 1993. It is an atypical antipsychotic medication used to treat schizophrenia and symptoms of bipolar disorder, in addition to symptoms of irritability in autistic children. Some doctors have also prescribed it to treat obsessive-compulsive disorder, stuttering, Tourettes syndrome, and severe... Read More

A young man who was only seven years old when he was prescribed the powerful antipsychotic Risperdal is suing Johnson & Johnson and its subsidiaries, claiming that he suffered a number of serious and permanent side effects of the drug, including the growth of male... Read More